Archive

Gauteng Health pay chaos sparks doctor fury

Gauteng Health pay chaos leaves public doctors without expected overtime payments, revealing deep systemic issues in healthcare.

Read More

Pharmaceutical tariffs could hike drug costs by billions

Learn how pharmaceutical tariffs could raise U.S. drug costs by nearly $51 billion and impact American consumers.

Read More

Australia’s Crumbling Universal Healthcare: What’s Wrong?

Examine the realities of Australia’s crumbling universal healthcare system and how funding problems are affecting patients nationwide.

Read More

Antibiotic Resistance Claims Lives of Premature Babies

Antibiotic resistance claims lives in South African neonates, creating a critical public health crisis for vulnerable infants.

Read More

HIV deaths in SA may be four times higher than reported

The latest SAMRC study uncovers severe underreporting of HIV deaths in SA, revealing gaps that demand urgent public health attention.

Read More

PEPFAR Funding Cuts Threaten South Africa’s Health

Discover the alarming predictions concerning PEPFAR funding cuts: 65,000 additional AIDS deaths and 300,000 new infections by 2028.

Read More

NHI causes uncertainty for medical schemes

NHI causes uncertainty with its ambitious goals in South Africa. Analyse the challenges to health financing reforms and public funding.

Read More

Adcock Ingram’s Urizone Wins Trademark Battle

Adcock Ingram’s Urizone receives legal protection as the court halts Cipla’s Furizome, citing trademark infringement.

Read More

Aspen Pharmacare Manufacturing Dispute Shrouded in Mystery

Explore the Aspen Pharmacare manufacturing dispute and its potential impact on core earnings for the 2025 financial year.

Read More

NHI Advertising Campaign Proceeds Despite HIV Funding Shortfall

Health Minister Aaron Motsoaledi discusses the NHI advertising campaign designed to address misinformation and support health efforts.

Read More

Lilly’s Orforglipron Shows Significant Weight Loss in Phase 3 Trial

Orforglipron can offer a new oral option for managing weight loss and blood sugar in type 2 diabetes treatment.

Read More

Clicks Interim Results Driven by Loyalty and Digital Sales

Read about the Clicks interim results that reveal a 13.2% rise in headline earnings per share and significant market achievements.

Read More